Form 8-K - Current report:
SEC Accession No. 0001571049-15-000942
Filing Date
2015-02-10
Accepted
2015-02-10 16:01:48
Documents
3
Period of Report
2015-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1500283_8k-x2.htm 8-K 17847
2 EXHIBIT 99.1 t1500283_ex99-1.htm EX-99.1 246369
3 GRAPHIC logo.jpg GRAPHIC 16250
  Complete submission text file 0001571049-15-000942.txt   288054
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 15593823
SIC: 2834 Pharmaceutical Preparations